Please make a donation to the Aplastic Anemia and MDS International Foundation this holiday season.
Join patients, families and caregivers for the 2023 Dallas, TX Patient and Family Conference This event is chaired and organized by Dr. Taha Bat from UT Southwestern.
From the 2023 Omaha Patient and Family Hybrid Conference: PNH Non-Transplant Therapies with Dr. Alex Nester. Learn symptom management and options for therapies in this session which includes questions from the audience.
Dr. Vijaya Bhatt discusses Low-Risk MDS in accessible terminology during this session from the 2023 Omaha, NE, Patient and Family Hybrid Conference.
Dr. Patel’s clinical and research expertise is in Blood and Marrow Transplantation (BMT). He has a particular interest in allogeneic hematopoietic cell transplantation as well as cellular therapies such as CAR-Ts for the treatment of malignant and benign hematologic diseases in adult patients. Dr. Patel’s research interests focus on the management of potential complications of such therapy including disease relapse and graft-versus-host disease. His work includes research and committee collaborations through such national and international organizations as ASTCT, CIBMTR, ASH, and EBMT.
High Risk MDS Non-Transplant Therapies Current Therapies and Clinical Trials with Dr. Prajwal Dhakal